DrugCite
Search

ADVAIR HFA

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Advair Hfa Adverse Events Reported to the FDA Over Time

How are Advair Hfa adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Advair Hfa, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Advair Hfa is flagged as the suspect drug causing the adverse event.

Most Common Advair Hfa Adverse Events Reported to the FDA

What are the most common Advair Hfa adverse events reported to the FDA?

Drug Ineffective
617 (7.73%)
Dyspnoea
423 (5.3%)
Asthma
353 (4.43%)
Dysphonia
276 (3.46%)
Cough
227 (2.85%)
Death
225 (2.82%)
Product Quality Issue
117 (1.47%)
Pneumonia
95 (1.19%)
Wheezing
84 (1.05%)
Chest Pain
81 (1.02%)
Chronic Obstructive Pulmonary Disea...
75 (.94%)
Show More Show More
Weight Increased
75 (.94%)
Candidiasis
70 (.88%)
Heart Rate Increased
69 (.86%)
Dizziness
67 (.84%)
Headache
67 (.84%)
Oral Candidiasis
67 (.84%)
Chest Discomfort
66 (.83%)
Tremor
58 (.73%)
Aphonia
56 (.7%)
Cataract
56 (.7%)
Fatigue
55 (.69%)
Ill-defined Disorder
55 (.69%)
Muscle Spasms
53 (.66%)
Overdose
50 (.63%)
Throat Irritation
50 (.63%)
Blood Pressure Increased
49 (.61%)
Palpitations
48 (.6%)
Dry Mouth
47 (.59%)
Adverse Event
45 (.56%)
Bronchitis
44 (.55%)
Dysgeusia
44 (.55%)
Nausea
44 (.55%)
Malaise
42 (.53%)
Rash
42 (.53%)
Respiratory Failure
41 (.51%)
Feeling Abnormal
39 (.49%)
Insomnia
39 (.49%)
Epistaxis
36 (.45%)
Anxiety
33 (.41%)
Condition Aggravated
33 (.41%)
Nervousness
33 (.41%)
Pain
33 (.41%)
Status Asthmaticus
32 (.4%)
Respiratory Arrest
31 (.39%)
Vision Blurred
31 (.39%)
Hypersensitivity
29 (.36%)
Cardio-respiratory Arrest
28 (.35%)
Vomiting
28 (.35%)
Medication Error
27 (.34%)
Pruritus
27 (.34%)
Arthralgia
26 (.33%)
Blood Glucose Increased
25 (.31%)
Bronchospasm
25 (.31%)
Cardiac Arrest
25 (.31%)
Laryngitis
25 (.31%)
Myocardial Infarction
25 (.31%)
Drug Administration Error
24 (.3%)
Dysphagia
24 (.3%)
Increased Upper Airway Secretion
24 (.3%)
Oral Fungal Infection
24 (.3%)
Respiratory Disorder
24 (.3%)
Swelling Face
24 (.3%)
Choking
23 (.29%)
Glossodynia
23 (.29%)
Hypertension
23 (.29%)
Lung Disorder
23 (.29%)
Nasopharyngitis
23 (.29%)
Oropharyngeal Pain
23 (.29%)
Stomatitis
23 (.29%)
Drug Exposure During Pregnancy
22 (.28%)
Loss Of Consciousness
22 (.28%)
Productive Cough
22 (.28%)
Anoxic Encephalopathy
21 (.26%)
Weight Decreased
21 (.26%)
Asthenia
20 (.25%)
Oedema Peripheral
20 (.25%)
Tachycardia
20 (.25%)
Therapeutic Response Decreased
20 (.25%)
Urticaria
20 (.25%)
Myalgia
19 (.24%)
Oral Pain
19 (.24%)
Visual Impairment
19 (.24%)
Anosmia
18 (.23%)
Dyspepsia
18 (.23%)
Fungal Infection
18 (.23%)
Heart Rate Irregular
18 (.23%)
Ageusia
17 (.21%)
Alopecia
17 (.21%)
Erythema
17 (.21%)
Hyperacusis
17 (.21%)
Pyrexia
17 (.21%)
Abdominal Pain Upper
16 (.2%)
Arrhythmia
16 (.2%)
Blindness Transient
16 (.2%)
Deafness Transitory
16 (.2%)
Diarrhoea
16 (.2%)
Lung Hyperinflation
16 (.2%)
Mouth Ulceration
16 (.2%)
Sinusitis
16 (.2%)
Dyspnoea Exertional
15 (.19%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Advair Hfa, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Advair Hfa is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Advair Hfa

What are the most common Advair Hfa adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Advair Hfa, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Advair Hfa is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Advair Hfa According to Those Reporting Adverse Events

Why are people taking Advair Hfa, according to those reporting adverse events to the FDA?

Asthma
1887
Drug Use For Unknown Indication
1225
Chronic Obstructive Pulmonary Disea...
674
Ill-defined Disorder
112
Emphysema
99
Dyspnoea
77
Show More Show More
Bronchitis
53
Product Used For Unknown Indication
39
Cough
23
Wheezing
19
Pneumonia
14
Lung Disorder
13
Respiratory Disorder
12
Hypersensitivity
8
Asthma Exercise Induced
8
Pulmonary Fibrosis
7
Bronchitis Chronic
5
Bronchospasm
4
Seasonal Allergy
3
Sarcoidosis
3
Multiple Allergies
3
Respiratory Tract Congestion
3
Bronchiectasis
3
Bronchial Hyperreactivity
3
Asthma Prophylaxis
2
Aspergillosis
2
Lung Neoplasm Malignant
2
Influenza
2
Prophylaxis
2
Lung Infection
2
Continuous Positive Airway Pressure
2
Upper Respiratory Tract Infection
2
Cystic Fibrosis
2
Mucous Membrane Disorder
1
Allergy To Animal
1
Chest Discomfort
1
No Therapeutic Response
1
Idiopathic Pulmonary Fibrosis
1
Pulmonary Function Test
1
Exercise Adequate
1
Chest Pain
1
Pneumonitis
1
Alpha-1 Anti-trypsin
1
Hypertension
1
Respiratory Distress
1
Lung Neoplasm
1
Quality Of Life Decreased
1
Sinus Disorder
1
Postnasal Drip
1
Respiratory Tract Infection Viral
1
Nasopharyngitis
1

Drug Labels

LabelLabelerEffective
Advair HfaGlaxoSmithKline LLC05-MAR-13

Advair Hfa Case Reports

What Advair Hfa safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Advair Hfa. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Advair Hfa.